Amyloidosis, Cardiac Failure, Coronary Artery Disease, Drug Toxicity, Lupus, Myocarditis, Sarcoidosis
Conditions
Keywords
MRI, SENC MyoStrain
Brief summary
Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice
Detailed description
Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice to determine how the use may alter treatment decisions and clinical outcomes in patients who are undergoing cardiac MRI.
Interventions
This test measures the contraction of the heart muscle in one to three heartbeats per plane. It's a pulse sequence that produces images that reveal the underlying contraction fo the muscle of a healthy heart and associated weaknesses in case of disease.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients already scheduled for diagnostic testing with commercially available imaging modality (cardiac MRI) * The patient population will include (but not limited to), those being evaluated for heart disease and heart failure that may be related to vascular disease (coronary artery disease), drug related heart failure (chemotherapy, alcohol), inflammatory systemic conditions (sarcoidosis, amyloidosis, lupus), myocarditis, and/or infectious etiologies * Provided written informed consent
Exclusion criteria
* Contraindication to Magnetic Resonance Imaging
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluate workflow for MyoStrain testing | Baseline | Survey the CMR interpreter to see how Myostrain impacted their interpretation and survey the referring clinician after receiving the CMR report. Survey Questions using 5-point Likert and binary reporting scale. The lower numbers represent positive feedback. Example listed below: CARDIAC MRI INTERPRETATION QUESTIONS FOR READER (CARDIOLOGIST OR RADIOLOGIST) How easy was it to interpret the additional Myostrain sequence information? 1 2 3 4 5 (1=Very Helpful 2=Helpful 3=Indifferent 4=Unhelpful 5=Very Unhelpful) |
Countries
United States